tirzepatide press release A new version of the popular diabetes treatment Mounjaro can be sold as a weight-loss drug, U.S. regulators announced Wednesday.⁠ ⁠ The U.S. Food and Drug Administration approved Eli Lilly's Zepbound, or CagriSema 2.4 mg/7.2 mg produced

Why Glutathione

The researchers concluded that GHRP-2, like ghrelin, increases food intake, suggesting that GHRP-2 [may be] a valuable tool for investigating ghrelin effects on eating behavior

Before anyone could consider a lunar landing, they had to prove the reliability of the orbit

After three months on semaglutide, most people have lost 5 to 8 percent of their body weight

Martin Holst Lange, executive vice president and chief scientific officer at Novo Nordisk, stated, Wegovy is now uniquely positioned as the first and only GLP-1 treatment approved for MASH. He noted that this approval complements the proven weight loss, cardiovascular benefits, and broader evidence linked to semaglutide

Diabetes, obesity & metabolism , 22 (10), 18861891